Fully Optimised Aptamers- Introducing Optimers
3rd October 2018
Proprietary process with validated improvement in delivery and performance
OptimersTM in 12 weeks
Aptamer Group is pleased to announce availability of OptimersTM – the new standard for our custom development services.
Aptamer Group is dedicated to continually improve its service offerings to identify the best reagent(s) from within our vast aptamer libraries in the shortest time possible. We are now including as standard our proprietary automated Minimal Aptamer Fragment Identification (MAFI) process for the development of kinetically optimised aptamers in the same delivery time as our previous approach. These improved aptamers will be differentiated from the standard library aptamers as Optimers.
Optimers can have multiple advantages, when compared to their precursor aptamer sequences, making kinetic optimisation an essential step in the development of the highest quality reagents against cellular, protein or small molecular targets.
Improved Development Timelines
- Fully optimised reagents without additional development time
- Improved Binding Kinetics and Specificity after optimisation.
- Reduced production costs, minimisation reduces the cost of production by over 50%.
If you are interested in reducing future assay costs, improving performance of your assay, downstream processing or therapeutic activity, then Optimer development would be the better solution.
If you are facing challenges that Optimers could address and are attracted by the benefits they offer, contact our team.